Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||
| Net Income | -22,208 | -7,300 | -11,174 |
| Depreciation Amortization | 308 | 265 | 149 |
| Accounts receivable | -142 | -746 | 490 |
| Accounts payable and accrued liabilities | 1,169 | -166 | -224 |
| Other Working Capital | -5,966 | 1,051 | 8,812 |
| Other Operating Activity | 135 | 2,364 | 614 |
| Operating Cash Flow | $-26,704 | $-4,532 | $-1,333 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -198 | -767 | -285 |
| Investing Cash Flow | $-198 | $-767 | $-285 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | N/A | 10,000 |
| Debt Repayment | -2,085 | 7,362 | -1,117 |
| Common Stock Issued | 53,458 | N/A | N/A |
| Other Financing Activity | -927 | 527 | 0 |
| Financing Cash Flow | $50,446 | $7,889 | $8,883 |
| Exchange Rate Effect | 13 | 410 | -482 |
| Beginning Cash Position | 17,373 | 14,373 | 7,590 |
| End Cash Position | 40,930 | 17,373 | 14,373 |
| Net Cash Flow | $23,557 | $3,000 | $6,783 |
| Free Cash Flow | |||
| Operating Cash Flow | -26,704 | -4,532 | -1,333 |
| Capital Expenditure | -198 | -767 | -285 |
| Free Cash Flow | -26,902 | -5,299 | -1,618 |